The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Open accessAbstract
BACKGROUND: Although much is known about the natural history of systemic lupus erythematosus (SLE), the development of SLE autoantibodies before the diagnosis of the disease has not been extensively explored. We investigated the onset and progression of autoantibody development before the clinical diagnosis. METHODS: The Department of Defense Serum Repository contains approximately 30 million specimens prospectively collected from more than 5 million U.S. Armed Forces personnel. We evaluated serum samples obtained from 130 persons before they received a diagnosis of SLE, along with samples from matched controls. RESULTS: In 115 of the 130 patients with SLE (88 percent), at least one SLE autoantibody tested was present before the diagnosis (up to 9.4 years earlier; mean, 3.3 years). Antinuclear antibodies were present in 78 percent (at a dilution of 1:120 or more), anti-double-stranded DNA antibodies in 55 percent, anti-Ro antibodies in 47 percent, anti-La antibodies in 34 percent, anti-Sm antibodies in 32 percent, anti-nuclear ribonucleoprotein antibodies in 26 percent, and antiphospholipid antibodies in 18 percent. Antinuclear, antiphospholipid antibodies, anti-Ro, and anti-La antibodies were present earlier than anti-Sm and anti-nuclear ribonucleoprotein antibodies (a mean of 3.4 years before the diagnosis vs. 1.2 years, P=0.005). Anti-double-stranded DNA antibodies, with a mean onset 2.2 years before the diagnosis, were found later than antinuclear antibodies (P=0.06) and earlier than anti-nuclear ribonucleoprotein antibodies (P=0.005). For many patients, the earliest available serum sample was positive; therefore, these measures of the average time from the first positive antibody test to the diagnosis are underestimates of the time from the development of antibodies to the diagnosis. Of the 130 initial matched controls, 3.8 percent were positive for one or more autoantibodies. CONCLUSIONS: Autoantibodies are typically present many years before the diagnosis of SLE. Furthermore, the appearance of autoantibodies in patients with SLE tends to follow a predictable course, with a progressive accumulation of specific autoantibodies before the onset of SLE, while patients are still asymptomatic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,406
Statistical Methods for Survival Data Analysis.
Lachenbruch, P. A., & Lee, E. T. (1993) · Journal of the American Statistical Association · doi:10.2307/2290742 · Cited by 2,845
SYSTEMIC LUPUS ERYTHEMATOSUS: REVIEW OF THE LITERATURE AND CLINICAL ANALYSIS OF 138 CASES
HARVEY, A. M., SHULMAN, L. E., TUMULTY, P. A., CONLEY, C. L., & SCHOENRICH, E. H. (1954) · Medicine · doi:10.1097/00005792-195412000-00001 · Cited by 993
D'Cruz, D. P., Khamashta, M. A., & Hughes, G. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60279-7 · Cited by 992
Wallace, D. J. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-5-436_2 · Cited by 658
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
Gharavi, A. E., Harris, E. N., Asherson, R. A., & Hughes, G. R. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.1.1 · Cited by 642
Aarden, L. A., Groot, E. R. D., & Feltkamp, T. E. W. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb29197.x · Cited by 563
A generalized two-sample Wilcoxon test for doubly censored data
GEHAN, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.3-4.650 · Cited by 346
James, J. A., Gross, T., Scofield, R. H., & Harley, J. B. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.453 · Cited by 339
Self-citationRuiz-Irastorza, G., Khamashta, M. A., Castellino, G., & Hughes, G. R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04239-2 · Cited by 257
Rheumatoid factors antedating clinical rheumatoid arthritis.
Aho, K., Heliövaara, M., Maatela, J., Tuomi, T., & Palosuo, T. (1991) · PubMed · Cited by 215
Development of Anti‐dsDNA Autoantibodies Prior to Clinical Diagnosis of Systemic Lupus Erythematosus
Arbuckle, M. R., James, J. A., Kohlhase, K. F., Rubertone, M. V., Dennis, G. J., & Harley, J. B. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.00959.x · Cited by 130
Self-citation(1976) · Postgraduate Medical Journal · doi:10.1136/pgmj.52.603.59-a · Cited by 111
Measurement of anti-DNA antibodies: a reappraisal using five different methods.
Isenberg, D. A., Dudeney, C., Williams, W., Addison, I. E., Charles, S., Clarke, J., & Todd-Pokropek, A. E. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.6.448 · Cited by 110
Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?
Spronk, P. E., ter Borg, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb05840.x · Cited by 107
Shared Early Autoantibody Recognition Events in the Development of Anti‐Sm B/B' in Human Lupus
Arbuckle, Reichlin, Harley, & James (1999) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1999.00640.x · Cited by 78
Implications of anti-Ro/Sjögren's syndrome A antigen autoantibody in normal sera for autoimmunity.
Gaither, K. K., Fox, O. F., Yamagata, H., Mamula, M. J., Reichlin, M., & Harley, J. B. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112892 · Cited by 75
Self-citationReview : Serological markers of disease activity in systemic lupus erythematosus
Spronk, P. E., Limburg, P. C., & Kallenberg, C. G. M. (1995) · Lupus · doi:10.1177/096120339500400202 · Cited by 71
Long-term outcome of mothers of children with isolated heart block in Finland
Julkunen, H. A., & Eronen, M. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200103)44:3<647::aid-anr113>3.0.co;2-i · Cited by 71
Clinical evaluation of various selected ELISA kits for the detection of anti-DNA antibodies
Aviña-Zubieta, J., Galindo-Rodriguez, G., Kwan-Yeung, L., Davis, P., & Russell, A. (1995) · Lupus · doi:10.1177/096120339500400507 · Cited by 30
Satoh, M., Yamagata, H., Watanabe, F., Nakayama, S. F., Ogasawara, T., Tojo, T., & Akizuki, M. (1995) · Lupus · doi:10.1177/096120339500400113 · Cited by 30
Azizah, M. R., Mn, A., Zulkifli, M. N., & Norita, T. Y. (1996) · PubMed · Cited by 25
Ma, Z., Rp, M., & Js, M. (1992) · PubMed · Cited by 24
Cited by
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Rovin, B. H., Furie, R., Latinis, K., Looney, R. J., Fervenza, F. C., Sanchez‐Guerrero, J., Maciuca, R., Zhang, D., Garg, J. P., Brunetta, P., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34359 · Cited by 1,461
Immune-related adverse events of checkpoint inhibitors
Ramos-Casals, M., Brahmer, J. R., Callahan, M. K., Flores-Chávez, A., Keegan, N., Khamashta, M. A., Lambotte, O., Mariette, X., Prat, A., & Suárez-Almazor, M. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0160-6 · Cited by 1,412
Merrill, J. T., Neuwelt, C. M., Wallace, D. J., Shanahan, J. C., Latinis, K. M., Oates, J. C., Utset, T. O., Gordon, C., Isenberg, D. A., Hsieh, H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27233 · Cited by 1,409
Kaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz-Irastorza, G., & Hughes, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,391
Metadata
- Authors
- Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-10-16
- Volume
- 349
- Issue
- 16
- Pages
- 1526-1533
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2078610240
- Cited by
- 2,578
- References
- 27
- FWCI
- 52.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.